Introduction

Albinism, derived from the Latin albus , meaning white, is an inherited disorder of melanin biosynthesis, which results in absent or reduced melanin production and causes a set of phenotypically heterogeneous conditions characterized by pigment deficiency. Melanogenesis requires complex interactions of enzymes and proteins within melanosomes to produce eumelanin (brown or black pigment) or pheomelanin (yellow or red pigment). This is coded for by a set of genes, whose mutations are known to cause albinism ( Fig. 40.1 ). Oculocutaneous albinism (OCA) and syndromes associated with OCA are inherited in an autosomal recessive manner, whereas ocular albinism (OA1) is associated with X-linked inheritance. Current terminology is based on the specific gene in which mutations can be found to define a particular type of albinism. Older terms, such as imperfect, incomplete, or complete albinism and tyrosinase-positive or tyrosinase-negative albinism, which were based on results of hair bulb incubation with l -tyrosine, are no longer used. Several laboratories provide panels for genetic testing of individuals with the phenotype of albinism.

Fig. 40.1, The pathway for normal melanogenesis results in production of eumelanin or pheomelanin.

Classification of albinism by genes affected

Non-syndromic oculocutaneous albinism

Although the rate of albinism varies geographically, albinism occurs with a frequency of approximately 1 in 20,000 worldwide, and more than 1% of the population carries a heterozygous mutation in a gene that causes albinism. The most common types are OCA1 and OCA2. OCA1 is due to mutations in the tyrosinase ( TYR ) gene, which is essential in the initial and rate-limiting steps of melanin biosynthesis. Persons with OCA1A (previously tyrosinase-negative) produce no melanin pigment in their skin, hair, or eyes over their lifetime. Those with OCA1B have some residual enzyme activity so they produce some melanin pigment in their hair, their eyelashes darken, their skin develops a slight tan, and melanin pigment can be detected in the posterior iris epithelium and occasionally in the macular retinal pigment epithelium (RPE) ( Fig. 40.2 ). OCA1 includes those diagnosed with minimal pigment or temperature-sensitive albinism, and those previously classified as having yellow albinism. Those with OCA2, due to the mutations in the OCA2 gene, often have blond or red hair at birth ( Fig. 40.3 ). Persons with OCA2 can often be difficult to distinguish from persons with OCA1B due to their pigmenting phenotype. In sub-Saharan Africa, there is a predominance of OCA2 due to a 2.7-kb interstitial deletion in OCA2 , related to a founder effect. Other types of OCA include OCA3, OCA4, OCA5, OCA6, OCA7, and OCA8 ( Table 40.1 ).

Fig. 40.2, Both boys have mutations in TYR . The boy on the left makes no melanin pigment (OCA1A) whereas the boy on the right makes a moderate amount of melanin pigment (OCA1B).

Fig. 40.3, This girl with African American heritage has mutations in the OCA2 gene that causes OCA2.

Table 40.1
Genetic classification of albinism
Type of albinism OMIM# Gene Locus Encoding function Comments
  • OCA1 *

  • OCA1A

  • OCA1B

  • 606933

  • 203100

  • 606952

TYR 11q14–21 Tyrosinase, which catalyzes several steps in melanogenesis OCA1A: no melanin; OCA1B: varying amounts of melanin are present
OCA2 203200 OCA2 (previously called P gene) 15q11.2–12 Melanosomal membrane protein Common in sub-Saharan Africa due to 2.7-kb deletion; includes brown OCA
OCA3 203290 TYRP1 9p23 Stabilizes tyrosinase and regulates eumelanin production Previously called red or rufous OCA
OCA4 696574 SLC45A2 (previously called MATP and AIM1 ) 5p13.2 Membrane transport protein Minimal to near normal melanin; phenotype similar to OCA2; common in Japan
OCA5 615312 Unknown 4q24 Unknown Described in Pakistani family
OCA6 609802 SLC24A 5 15q21.1 Melanosome maturation Described in Chinese family
OCA7 615179 C10orf11 10q22.2–q22.3 Melanocyte differentiation Described in families in Faroe Islands and Denmark
OCA8 NA DCT/TYRP2 13q32.1 Enzyme catalyst in melanogenesis Described in a French girl and a North African woman
OA1 300500 GPR143 Xp22.2–22.3 Regulation of melanosome distribution Nettleship–Falls OA; pigmentary mosaicism in obligate carrier
HPS-1 203300 HPS1 10q23.1–23.3 Transmembrane protein in BLOC-3 within BLOC-4 and BLOC-5 Common in northwestern Puerto Rico due to founder effect; progressive pulmonary fibrosis and colitis
HPS-2 608233 ADTB3A , AP3B1 , HPS2 5q14.1 Lysosomal trafficking Neutropenia and/or immune defects; pulmonary fibrosis, conductive hearing loss, dysplastic hip
HPS-3 614072 HPS3 , BLOC2S1 3q24 Vesicle-related protein Found in central Puerto Rico; mild systemic findings; colitis
HPS-4 614073 HPS4 , BLOC3S2 22q11.2–12.2 Involved in BLOC-3 and BLOC-4 Pulmonary fibrosis, colitis
HPS-5 614074 HPS5 , RU2 , KIAA1017 , BLOC2S2 11p15–p.13 Organelle biogenesis Mild phenotype; hyperlipidemia, elevated creatinine clearance in some
HPS-6 614075 HPS6 , RU , BLOC2S3 10q24.32 Organelle biogenesis Mild systemic findings
HPS-7 614076 DTNBP1 , HPS7 , BLOC1S8 6p22.3 Component of BLOC-1 Mild lung disease
HPS-8 614077 BLOC1S3 , HPS8 19q13.32 Vesicular transport protein Mild systemic findings
HPS-9 614171 BLOC1S6 , PLDN , PA , HPS9 15q21.1 Intracellular vesicle trafficking Few cases described
HPS-10 617050 AP3D1 , HPS10 19q13.32 Lysosomal biogenesis Microcephaly, seizures, immunodeficiency
HPS-11 NA BLOC1S5 6p24.3 Lysosomal biogenesis; cargo transport Few cases described
CHS 214500 LYST (previously CHS1 ) 1q42.1–42.2 Lysosomal trafficking regulator protein Frequent infections due to immunodeficiency; may have bleeding diathesis
AP, adapter protein; BLOC, biogenesis of lysosomal-related organelles complex; CHS, Chédiak–Higashi syndrome; DCT, dopachrome tautomerase; GPR, G protein-coupled receptor; HPS, Hermansky–Pudlak syndrome; LYST, lysosomal trafficking regulator; NA, not available; OA, ocular albinism; OCA, oculocutaneous albinism; OMIM, Online Mendelian Inheritance in Man ( omim.org ); PLDN, pallidin; SLC, solute carrier family; TYRP1, tyrosine-related protein-1; TYRP2, tyrosine-related protein-2.

* OCA1 includes previously described temperature-sensitive OCA, minimal pigment OCA, and yellow OCA.

Syndromic oculocutaneous albinism

Syndromes associated with OCA are less common than non-syndromic albinism and include Hermansky–Pudlak syndrome (HPS), occurring with a frequency of approximately 1–9 per 1,000,000 persons worldwide, although certain types have a greater prevalence in particular areas (e.g. 1 in 1800 in northwest Puerto Rico due to founder mutations in HPS-1). In HPS, affected individuals have absent dense bodies (delta granules) in their platelets, which interferes with the secondary phase of aggregation to exogenous stimuli. Thus, individuals with HPS have easy bruising, epistaxis, and prolonged bleeding after procedures such as dental extraction, childbirth, and surgery. Eleven types of HPS have been identified to date, and all have autosomal recessive inheritance causing abnormalities in proteins involved in the biogenesis of lysosome-related organelles (e.g. melanosomes, dense granules in platelets). Some types are associated with pulmonary fibrosis and intestinal accumulation of ceroid, causing granulomatous colitis/inflammatory bowel disease (see Table 40.1 ). Whole-mount electron microscopy of platelets without dense bodies can identify those with HPS, but genetic testing identifies the specific type of HPS and the potential for other systemic abnormalities. The phenotype for OCA in HPS is variable and can overlap with non-syndromic types of albinism. Genetic testing may be necessary to establish the diagnosis.

Chédiak–Higashi syndrome (CHS), inherited as an autosomal recessive disorder, is also associated with OCA. Persons with CHS have frequent infections and can progress to a lymphoproliferative phase. They are treated with hematopoietic stem cell transplantation, preferably prior to the accelerated phase. If untreated, they will also develop neurological abnormalities and eventually succumb to an overwhelming infection. Although these individuals have the ocular and cutaneous features of albinism, their hair has a subtle silvery sheen, often prompting investigation to establish the diagnosis. Peripheral blood smear shows giant intracellular granules in neutrophils.

Ocular albinism

In ocular albinism (OA1), which occurs less frequently than OCA, there is a mutation in the GPR143 gene on the X chromosome. Males with OA1 have the typical ocular features of albinism, but their cutaneous and hair pigment is nearly normal. Some may have hypopigmented macules; skin biopsy may show macromelanosomes, but they are not pathognomonic. Without careful eye examination, these individuals may be identified as having uncomplicated infantile nystagmus syndrome. Mothers of children with OA1 will typically show some iris transillumination and pigmentary mosaicism in the retina ( Fig. 40.4 ), unless the child has a new mutation; the obligate carrier is rarely symptomatic. Pigmentary mosaicism, noted in 80%–90%, represents expression of Lyonization with pigmented RPE adjacent to non-pigmented areas, most notable in the mid-periphery of the fundi. Some males and females with almost normal pigmentation have been given a diagnosis of autosomal recessive ocular albinism, but many have been found to have OCA with genetic testing, most often due to mutations in the TYR gene. If a deletion in GPR143 occurs, contiguous genetic disorders may be associated with OA1, e.g. ichthyosis of the skin ( STS ), Kallman syndrome ( KAL1 ), and chondrodysplasia punctata ( ARSL ).

Fig. 40.4, Examination of the fundus of the obligate carrier for OA1 typically shows pigmentary mosaicism, with some areas having normal melanin pigment and other areas having no melanin pigment, as a manifestation of Lyonization.

Clinical phenotype

Ocular features

The ocular features in albinism vary from one individual to another, within a family, and within a specific type of albinism, due to interaction of heterogeneity in the type of albinism and the constitutional genotypes. A clinical diagnosis of albinism is based on a constellation of findings and may be confirmed with genetic testing.

Reduced visual acuity

Many parents report that their infants with albinism close their eyes when exposed to bright light and do not appear to be as visually attentive as their children without albinism, but most agree that visual attentiveness improves by 5–6 months of age. Vision often continues to improve as the child matures but rarely becomes normal. The spectrum of best-corrected visual acuity in persons with albinism ranges from 20/20 to worse than 20/400. A spectrum of visual acuity is noted across and within the different types of albinism, and persons with OCA1A generally have worse visual acuity than persons with other types of albinism. High refractive errors are common in albinism, with large amounts of astigmatism being particularly noted in OCA1A. Early correction of large refractive errors and careful re-evaluation of the refractive error over time maximizes the visual outcome by reducing ametropic amblyopia and improving binocular alignment. Other reasons for reduced visual acuity include foveal hypoplasia, light scattering, nystagmus, and possibly retinostriate misrouting. Certain features associated with relatively better visual outcomes include demonstration of some stereoacuity and the presence of granular melanin pigment in the macula with clinical evidence of macular differentiation.

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here